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Background

Post-Tonsillectomy Polysomnography Results

22q11.2 deletion syndrome (22qDS) is a common genetic
disorder with an estimated risk of obstructive airway
symptoms in 10-37% of affected children. While
tonsillectomy is commonly pursued in an effort to ameliorate
airway obstruction, there are currently no published studies
evaluating tonsillectomy outcomes in children with 22qDS.
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Objective
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To investigate the indications, efficacy, and complications of
tonsillectomy in a large cohort of patients with 22qDS.
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Methods and Materials
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We performed a retrospective chart review of 168 consecutive
patients with 22qDS from the institution’s 22q repository from
1/1/2010-6/1/2021. Data was collected for tonsillectomy
indications, length of hospital stay, complications, and preand postoperative sleep study results.
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Discussion
Tonsillectomy was a commonly performed procedure in this
large cohort of patients with 22qDS. Facilitation of speech
surgery and sleep disordered breathing/OSA were the most
common indications. Most patients experienced swift recovery
with one night in the hospital prior to discharge, although
these data highlight the potential need for close postoperative
calcium and respiratory monitoring. Of note, for the eight
patients that had postoperative calcium monitoring, 50% had
hypocalcemia. Our data were limited with respect to
polysomnographic outcomes. While a majority of this cohort
had persistent OSA following tonsillectomy, we had only 3
patients with both pre- and post-operative sleep studies. This
makes it difficult to comment on the success of tonsillectomy
in treating OSA for this patient population.

Results
Thirty-three of the 168 (20%) patients with 22qDS in our
sample underwent tonsillectomy. Indications for tonsillectomy
included: to facilitate with speech surgery (n=21), sleep
disordered breathing/obstructive sleep apnea (OSA) (n=16),
dysphagia (n=3), and airway management prior to trach
decannulation (n=2). Average length of stay was 1.15 days
(range 0-4 days). Six patients had a preoperative sleep study,
10 patients had a postoperative sleep study, and 3 patients had
both pre- and post-operative sleep studies. Of those children
who had postoperative sleep studies, 3 were normal, 5 had
mild OSA, 1 had moderate OSA, and 1 had severe OSA.
Three patients presented with postoperative tonsil bleeds, of
whom 1 required surgical cauterization and 2 recovered with
observation alone. Of the 8 patients who had postoperative
calcium monitoring, 4 (50%) had hypocalcemia and received
an endocrinology consultation; 1 patient was treated with oral
supplementation, and 3 were observed with repeat labs. One
patient experienced postoperative respiratory failure requiring
overnight intubation.
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Mild OSA

Postoperative Calcium Monitoring
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• Patients undergoing tonsillectomy
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• Patients who had post-op calcium testing
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• Patients with post-op hypocalcemia
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• Patient requiring intervention for hypocalcemia

Indications for Tonsillectomy in Patients with 22qDS

Conclusions
20

Tonsillectomy is common in patients with 22qDS. Providers
should consider overnight observation and postoperative
calcium monitoring following tonsillectomy. Future studies
are needed to better characterize sleep disordered
breathing/OSA outcomes following tonsillectomy for patients
with 22qDS.
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Facilitate with speech surgery

Sleep disordered breathing/OSA

Dysphagia

Airway optimization prior to trach decannulation
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